JLE

Hépato-Gastro & Oncologie Digestive

MENU

Traitement de l’endobrachyœsophage Volume 18, issue 1, Janvier-Février 2011

Figures

See all figures

Authors
CHU de la Cavale-Blanche, service d’hépatogastroentérologie, boulevard Tanguy-Prigent, 29609 Brest Cedex, France, Institut des maladies de l’appareil digestif de Nantes, CHU Hôtel-Dieu, service d’hépatogastroentérologie 44093 Nantes Cedex, France

The development of therapeutic endoscopy can now offer an effective alternative to esophagectomy in Barrett patients with high-grade dysplasia or early carcinoma. Endoscopic treatment has to be complete and only lesions with a low-risk of lymph node involvement (high-grade dysplasia and intramucosal carcinomas) can be treated endoscopically with a curative intent. The risk of progression of dysplastic lesions within the Barrett's esophagus justifies the eradication of all the residual mucosa; thus, approaches combining techniques of resection of visible abnormalities and ablation techniques are currently recommended.